Join the club for FREE to access the whole archive and other member benefits.

David Rubinsztein

CIMR Deputy Director, Professor of Molecular Neurogenetics and UK Dementia Research Institute Professor.

From a background in medicine, David Rubinsztein became Professor of Molecular Neurogenetics at the University of Cambridge in 2005. Obtaining his PhD from the University of Cape Town, he went on to lead the way in research of autophagy in neurodegenerative disease, with his lab discovering its role in intracytoplasmic aggregate-prone proteins. Author of more than 300 scientific papers, he has received numerous awards, including the Thudichum Medal (Biochemical Society) for outstanding contributions to neuroscience, the Roger de Spoelberch Prize, membership of EMBO, and fellowships of the Royal Society and the Academy of Medical Sciences.

Visit website:


See also: Academia University of Cambridge - Collegiate research university in Cambridge, United Kingdom

Details last updated 13-Feb-2020

David Rubinsztein is also referenced in the following:

BSRA Annual Scientific Meeting 2023

06-Sep-2023 to 08-Sep-2023

A compelling lineup of speakers from all areas of the biology of ageing

David Rubinsztein News

Can autophagy boost your health?

BBC - 06-May-2018

Autophagy is the process by which cells degrade and recycle their components. Helps infection co...